Skip to content
Homepage
Condition Guide

Long COVID: Symptoms, Evidence, and Finding Care

Treatment outlook Emerging
Written by Senior Health and Wellness Writer
Reviewed by Expert in Regenerative & Longevity Medicine, Bioidentical Hormone Therapy, and Pediatric Precision Health

This page is for people whose symptoms did not clear weeks or months after COVID-19 — and for caregivers trying to make sense of care options without hype. It is also for readers who were told labs look “fine” while they still cannot work, exercise, or think clearly.

You will find plain-language definitions, how researchers talk about mechanisms (with uncertainty labeled), what conventional care usually offers, how we grade regenerative claims, red flags to avoid, questions to bring to a clinician, and links into our Directory so you can find clinics — without cure promises.

### What it is (plain language)

**Long COVID** is a multi-system condition in which symptoms continue, return, or newly appear after an acute COVID-19 infection. It is also called **post-COVID condition**, **long-haul COVID**, or **PASC** (post-acute sequelae of SARS-CoV-2). Presentation is **heterogeneous**: two people with the same label can look very different.

There is no single confirmatory lab test. Definitions used in research and clinics vary by duration and symptom set.

**What we do not claim:** a single cause, a single timeline for recovery, or a cure.

### Why care is hard to navigate

Long COVID sits awkwardly between specialties — primary care, pulmonology, cardiology, neurology, autonomic clinics, rehab, psychiatry — while many people also meet patterns that overlap **ME/CFS**, **POTS**, or **MCAS**-type symptoms. Normal basic labs are common. That combination produces dismissal, fragmented workups, and a marketplace eager to sell certainty.

Overlap with sibling conditions is real. **Overlap is not identity.** Long COVID and ME/CFS can share features (especially post-exertional malaise), but they are not the same diagnosis and should not be collapsed in care planning or marketing.

Frequently asked questions

Common questions about regenerative approaches to Long COVID.

Yes. It is recognized as a post-infection condition with multi-system symptoms. Recognition does not mean every marketed treatment is proven.

No. They can overlap — especially when PEM is present and some people meet ME/CFS criteria after COVID. Overlap ≠ identity. Care should address the pattern you actually have.

Usually not as a single diagnostic blood test. Normal labs do not rule it out. Testing is mainly to exclude other causes and guide symptom care.

It varies widely. Some people improve over months; others have prolonged courses. We do not invent average timelines here — ask your clinician and track function over time.

Some people improve with time and supportive care. That is not a promise, and it does not mean untreated complications should be ignored.

Start with a clinician who takes post-COVID illness seriously and screens for PEM and autonomic issues. Multidisciplinary post-COVID clinics exist in some regions; otherwise coordinate primary care with relevant specialists.

Yes. Long COVID is a real, multi-system biological condition, not anxiety and not simply being out of shape. Research has documented concrete mechanisms, including lingering viral material in tissue, immune dysregulation, tiny persistent blood clots, mitochondrial dysfunction, and disruption of the autonomic nervous system. Most patients have several of these at once, which is why symptoms are so varied.

Usually not on standard tests. Routine bloodwork and basic inflammatory markers often come back normal, and no single test confirms long COVID, so it is diagnosed clinically from your history after other causes are ruled out. Normal results do not mean nothing is wrong; research groups have found abnormalities in autonomic function, immune activity, and microclots. Microclot testing is a research method with no validated clinical version, and the blood-thinning and apheresis protocols sold on the back of it are untested in controlled trials and carry bleeding risk.

Brain fog is one of the most common and disruptive long COVID symptoms, affecting memory, concentration, word-finding, and mental stamina. It stems from the same biology driving the rest of the condition: neuroinflammation, impaired blood flow through tiny vessels, and mitochondrial dysfunction. For many people it eases as the underlying drivers are addressed and crashes from overexertion are avoided.

It can cause both, through two overlapping routes. The neuroinflammation and physiological disruption behind long COVID can directly affect mood, so depression and anxiety can be part of the illness itself, and living with a debilitating, often dismissed condition takes its own emotional toll. Both are treatable, and recognizing the biological component counters the idea that long COVID is imagined.

No honest Guide can claim that. Some modalities are being studied or used supportively; grades above apply. Be skeptical of cure ads.

A fluctuating course is typical, with symptoms easing during better stretches and returning during flares. A hallmark is post-exertional malaise, where exertion triggers a crash a day or two later, so overdoing it on a good day often leads to a worse one. This does not mean you are back to square one, but it makes pacing important.

It can be disabling for some people. Benefits and legal status depend on jurisdiction and documentation — this is not legal advice. Ask a qualified advocate or clinician about functional documentation.

References

Castanares-Zapatero, D., Chalon, P., Kohn, L., Dauvrin, M., Detollenaere, J., Maertens de Noordhout, C., Primus-de Jong, C., Cleemput, I., & Van den Heede, K. (2022). Pathophysiology and mechanism of long COVID: A comprehensive review. Annals of Medicine, 54(1), 1473-1487. https://doi.org/10.1080/07853890.2022.2076901

Hadanny, A., Zilberman-Itskovich, S., Catalogna, M., Elman-Shina, K., Lang, E., Finci, S., Polak, N., Shorer, R., Parag, Y., & Efrati, S. (2024). Long-term outcomes of hyperbaric oxygen therapy in post-COVID condition: Longitudinal follow-up of a randomized controlled trial. Scientific Reports, 13, 21953. https://doi.org/10.1038/s41598-024-53091-3

Kell, D. B., Khan, M. A., & Pretorius, E. (2024). Fibrinaloid microclots in long COVID: Assessing the actual evidence properly. Research and Practice in Thrombosis and Haemostasis, 8(7), Article 102566. https://pmc.ncbi.nlm.nih.gov/articles/PMC11491705

Wong, T. L., & Weitzer, D. J. (2021). Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) - A systemic review and comparison of clinical presentation and symptomatology. Medicina, 57(5), Article 418. https://pubmed.ncbi.nlm.nih.gov/33925784/

World Health Organization. (2025, February 25). Post COVID-19 condition (long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition

Yuan, M.-Q., Song, L., Wang, Z.-R., Zhang, Z.-Y., Shi, M., He, J., Mo, Q., Zheng, N., Yao, W.-Q., Zhang, Y., Dong, T., Li, Y., Zhang, C., Song, J., Huang, L., Xu, Z., Yuan, X., Fu, J.-L., Zhen, C., Cai, J., Dong, J., Zhang, J., Xie, W.-F., Li, Y., Zhang, B., Shi, L., & Wang, F.-S. (2025). Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial. Stem Cell Research & Therapy, 16, 94. https://pmc.ncbi.nlm.nih.gov/articles/PMC11863646/

Zheng, Z. S., Simonian, N., Wang, J., & Rosario, E. R. (2024). Transcutaneous vagus nerve stimulation improves Long COVID symptoms in a female cohort: A pilot study. Frontiers in Neurology, 15, Article 1393371. https://pmc.ncbi.nlm.nih.gov/articles/PMC11097097/

Zilberman-Itskovich, S., Catalogna, M., Sasson, E., Elman-Shina, K., Hadanny, A., Lang, E., Finci, S., Polak, N., Fishlev, G., & Efrati, S. (2022). Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: Randomized controlled trial. Scientific Reports, 12, 11252. https://doi.org/10.1038/s41598-022-15565-0

About this article

Written by

Diana Bocco is a health and wellness writer with a focus on evidence-based content. Her work covers nutrition, preventive health, and the role of daily habit...

Medically reviewed by

Dr. Bronwyn Holmes, MD, FAARFM

Dr. Bronwyn Holmes is a board-certified physician and the founder of Bronwyn MD, a private concierge practice with origins in New York City, now based in Los...

Dealing with Long COVID?

Talk to a healthcare professional about Long COVID to understand your treatment options and develop a personalized care plan.